Lipid-lowering therapy after myocardial infarction: is it worth it?
作者信息
Warnica J W
出版信息
CMAJ. 1997 Apr 1;156(7):1005-7.
Abstract
摘要
相似文献
1
Lipid-lowering therapy after myocardial infarction: is it worth it?心肌梗死后的降脂治疗：是否值得？
CMAJ. 1997 Apr 1;156(7):1005-7.
2
[Statines for all or individualized lipid lowering therapy?].
MMW Fortschr Med. 2009 Apr 2;151(14):100, 102-4; quiz 105.
3
Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006.1998年至2006年急性心肌梗死患者出院时降脂药物的使用趋势
Am Heart J. 2009 Jan;157(1):185-194.e2. doi: 10.1016/j.ahj.2008.09.001. Epub 2008 Oct 29.
4
Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.急性心肌梗死后的药物处方：剂量、依从性和持续性。
Am Heart J. 2003 Mar;145(3):438-44. doi: 10.1067/mhj.2003.143.
5
Rationale for aggressive lipid lowering: evidence from clinical trials.
Expert Rev Cardiovasc Ther. 2004 May;2(3):305-9. doi: 10.1586/14779072.2.3.305.
6
Letter by Ben-Dov and Bursztyn regarding article, "Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial".本-多夫和布尔兹廷就文章《利尿剂在预防心力衰竭中的作用：预防心脏病发作的抗高血压和降脂治疗试验》所写的信函。
Circulation. 2007 Jan 16;115(2):e18; author reply e19. doi: 10.1161/CIRCULATIONAHA.106.639617.
7
Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.强化降脂方案与标准降脂方案治疗急性冠脉综合征的疗效比较：普伐他汀或阿托伐他汀评估与感染治疗-心肌梗死溶栓22（PROVE IT-TIMI 22）试验结果
Am J Med. 2005 Dec;118 Suppl 12A:28-35. doi: 10.1016/j.amjmed.2005.09.014.
8
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
J Hum Hypertens. 2003 Jun;17(6):367-72. doi: 10.1038/sj.jhh.1001556.
9
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.既往降脂治疗与急性心肌梗死患者梗死面积（肌酸激酶-MB水平）之间的关系。
Am J Cardiol. 2008 Nov 1;102(9):1119-24. doi: 10.1016/j.amjcard.2008.06.032. Epub 2008 Aug 27.
10
Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?消除自付药品费用可能会改善心肌梗死后的治疗效果——但这对医疗保险来说要付出什么代价呢？
Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):606-7. doi: 10.1038/ncpcardio1309. Epub 2008 Aug 12.
Zotero 插件